FDA Issues Emergency Use Authorization for Impella RP as Therapy for COVID-19 Patients With Right Heart Failure
June 1, 2020—Abiomed announced that the FDA has issued an emergency use authorization (EUA) for the company’s Impella RP to include patients with COVID-19–related right heart failure or decompensation, including pulmonary embolism (PE).
Analysis of LEADERS FREE Supports Similar PCI Treatment in Women as in Men With High Bleeding Risk
May 29, 2020—The American College of Cardiology announced a recently published study that demonstrated that women with high bleeding risk should not be denied the benefits of percutaneous coronary intervention (PCI) when indicated and that bleeding avoidance strategies should be uniformly adopted for all patients, especially in women.
SMT Enters Structural Heart Market With Acquisition of Vascular Concepts
May 28, 2020—Sahajanand Medical Technologies Pvt Ltd (SMT), a global medical device company based in India, announced its entry into the structural heart segment with the acquisition of Vascular Concepts, which is also headquartered in India.
PROTECT III Evaluates Abiomed’s Impella Placement Before High-Risk PCI
May 19, 2020—Abiomed announced that data from more than 1,000 patients demonstrated that the company’s Impella device reduces in-hospital mortality when placed before a nonemergent percutaneous coronary intervention (PCI) is performed.
SCAI Position Statement Addresses Optimal PCI Therapy for Complex CAD
May 14, 2020—The Society for Cardiovascular Angiography and Interventions (SCAI) announced the publication of an official position statement on optimal percutaneous coronary intervention (PCI) treatment of patients with complex coronary artery disease (CAD).
MedAlliance Gains CE Mark Approval for Coronary Selution SLR Sirolimus-Eluting Balloon
May 14, 2020—MedAlliance SA announced European CE Mark approval for the Selution SLR 014, a sirolimus drug-eluting balloon (DEB) with sustained limus-release (SLR) for the percutaneous transluminal coronary angioplasty to treat of coronary artery disease.
CHOW NOW Study Compares Eating Versus Fasting Before Cardiac Catheterizations
May 14, 2020—The Society for Cardiovascular Angiography and Interventions (SCAI) announced findings from the single-center, randomized CHOW NOW study that aimed to compare the safety and clinical outcomes of a nonfasting (NF) strategy as compared with the current standard fasting (SF) protocol.
TWILIGHT Substudy Compares Safety of Bioabsorbable Polymer and Durable Polymer DES in High-Risk Patients Undergoing PCI
May 14, 2020—The Society for Cardiovascular Angiography and Interventions (SCAI) announced that subgroup findings from the TWILIGHT trial sought to reveal whether drug-eluting stents (DESs) coated with a bioabsorbable polymer (BP) provided a safety advantage without compromising efficacy compared with durable polymer (DP) formulations.
Telemedicine-Based Network Makes Remote PCI Guidance Available to 100 Million Patients
May 14, 2020— Findings from the LATIN study were presented as late-breaking science during the Society for Cardiovascular Angiography and Interventions (SCAI) 2020 Scientific Sessions Virtual Conference held May 14–16, 2020.
Study Compares Multivessel Versus Culprit-Vessel PCI in Cardiogenic Shock
April 29, 2020—Alejandro Lemor, MD, et al conducted a study to compare outcomes of patients enrolled in the National Cardiogenic Shock Initiative trial who were treated using a percutaneous coronary intervention (PCI) revascularization strategy of either multivessel PCI (MV-PCI) or culprit-vessel PCI (CV-PCI).
SCAI and CAIC Announce the Formation of the North American COVID-19 STEMI Registry
April 27, 2020—The Society for Cardiovascular Angiography and Interventions (SCAI) and the Canadian Association of Interventional Cardiology (CAIC) recently announced the formation of the North American COVID-19 ST-segment elevation myocardial infarction (STEMI) Registry (NACMI).
EARLY Trial Evaluates Optimal Timing of Intervention in NSTE-ACS Without Pretreatment
April 27, 2020—Findings from the EARLY randomized trial comparing a delayed versus a very early invasive strategy in patients with non–ST-segment elevation acute coronary syndromes (NSTE-ACS) without pretreatment were published by Gilles Lemesle, MD, et al in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions (2020;13:907–917).
AHA/ACC Key Data Elements and Definitions for Coronary Revascularization Published
April 27, 2020—The American College of Cardiology and American Heart Association's (ACC/AHA) Task Force on Clinical Data Standards have produced the “2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization.” The document was published by Gregory J. Dehmer, MD, et al of the Writing Committee to Develop Clinical Data Standards for Coronary Revascularization in Journal of the American College of Cardiology (2020;75;1975–2088).
Multisociety Consensus Statement Focuses on Management of AMI Patients During COVID-19
April 20, 2020—The American College of Cardiology (ACC) announced the publication of a consensus statement from ACC, the Society for Cardiovascular Angiography and Interventions, and the American College of Emergency Physicians that outlines recommendations for a systematic approach for the care of patients with acute myocardial infarction (AMI) during the COVID-19 pandemic.
Sponsored by Penumbra, Inc.
Massive Pulmonary Embolism: The Role of Mechanical Circulatory Support
Use of mechanical circulatory support appears to be feasible in a subset of patients with pulmonary embolism, but expertise in placement and postprocedural management is critical.
By Catalin Toma, MD; Michael Jolly, MD; and Christopher Huff, MD
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available interventional cardiology devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available interventional cardiology devices in Europe.